Trial intelligence / Profile preview

Ciprofol versus propofol for pharyngeal function suppression during outpatient painless gastroscopy

ChiCTR2100054446Phase 4Recruiting

Sponsor
Affiliated Hospital of Chengdu University
Start
Apr 2021
Modality
Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, open-label trial of ciprofol and propofol (2 arms), sponsored by Affiliated Hospital of Chengdu University. Primary endpoint: Positive rate of pharyngeal reflex. Started Apr 2021; status: recruiting.

02

Drugs

ciprofolpropofol

Beyond the preview

Go deeper on ChiCTR2100054446.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2100054446.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call